Desjardins Global Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$257K Buy
2,074
+282
+16% +$28.8K 0.03% 318
2023
Q3
$167K Sell
1,792
-1,773
-50% -$200K 0.02% 402
2023
Q2
$458K Buy
3,565
+678
+23% +$82K 0.05% 306
2023
Q1
$335K Buy
2,887
+1,698
+143% +$190K 0.04% 330
2022
Q4
$134K Buy
1,189
+35
+3% +$3.84K 0.02% 377
2022
Q3
$92K Hold
1,154
0.01% 393
2022
Q2
$86K Buy
+1,154
New +$105K 0.01% 390

Other funds holding DXCM

Desjardins Global Asset Management's DXCM Position: Q4 2023 in Review

Desjardins Global Asset Management increased its DexCom (DXCM) stake by 16% in Q4 2023, buying an estimated $28.8K and bringing the position to 2,074 shares worth $257K. The position accounts for 0.03% of the portfolio, ranked #318.

Desjardins Global Asset Management first reported a position in DXCM in Q2 2022 and has held it in 7 quarters since. The position peaked at $458K in Q2 2023. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • Desjardins Global Asset Management held 2,074 shares of DexCom worth $257K as of Q4 2023.
  • Desjardins Global Asset Management bought 282 DexCom shares in Q4 2023, an estimated $28.8K.
  • DexCom made up 0.03% of Desjardins Global Asset Management's portfolio in Q4 2023, its #318 holding.
  • Desjardins Global Asset Management first reported a position in DexCom in Q2 2022 and has held it in 7 quarters since.
  • Desjardins Global Asset Management's DexCom position peaked at $458K in Q2 2023.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.